发明名称 СПОСОБ ВЫБОРА КОРРЕКТИРУЮЩЕГО ПОДХОДА ДЛЯ ЛЕЧЕНИЯТРОМБОЦИТОПАТИИ ПРИ МЕТАБОЛИЧЕСКОМ СИНДРОМЕ
摘要 FIELD: medicine, cardiology, endocrinology, hematology. ^ SUBSTANCE: the present innovation deals with matching differentiated therapy of thrombopathy in patients with metabolic syndrome. One should detect thrombocyte aggregation index in three transfer tests - collagen, collagen-aspirin and collagen-imidazole. Depending upon the value of collagen test and the ratios of collagen-aspirin and collagen, and, also, collagen-imidazole and collagen tests one should prescribe differentiated therapy. Such therapy deals with hypocaloric diet, dosed physical loading and introduction of metformin at the dosage of 500 mg twice daily at different combinations. Such differentiated approach provides efficient correction of thrombopathy in case of metabolic syndrome. ^ EFFECT: higher efficiency. ^ 4 ex, 1 tbl
申请公布号 RU2005123664(A) 申请公布日期 2007.05.10
申请号 RU20050123664 申请日期 2005.07.25
申请人 Медведев Иль  Николаевич (RU);Наумов Михаил Михайлович (RU);Беспарточный Борис Дмитриевич (RU) 发明人 Медведев Иль  Николаевич (RU);Наумов Михаил Михайлович (RU);Беспарточный Борис Дмитриевич (RU);Баскаков Евгений Валерьевич (RU)
分类号 A61K35/00 主分类号 A61K35/00
代理机构 代理人
主权项
地址